Patient-reported outcomes and the management of prostate cancer

Andrew Vickers, PhD, who works at the Memorial Sloan-Kettering Cancer Center in New York, is not a physician. He is a statistician and a research methodologist. And he is a member of the Scientific Advisory Board to The “New” Prostate Cancer InfoLink. … READ MORE …

Evidence for dose escalation in adjuvant/salvage radiation

It is well known that prostate cancer is relatively radio-resistant compared to other kinds of cancer. … READ MORE …

The role of nutrition in management of prostate cancer patients on ADT

The precise roles of nutrition and exercise in the prevention of prostate cancer (if any) and in the management of the health of men with prostate cancer (at various different stages) are a subject of constant concern to the patient community — and to the caregiver community too. … READ MORE …

New urine test shows promising results in detecting, classifying risk for prostate cancer

A newly published article in BJU International has described a way to test post-DRE urine samples for the presence of specific types of ribonucleic acid (RNA) and use these data to detect and classify risk levels for more and less aggressive forms of prostate cancer. … READ MORE …

Mutations to FOXA1 may be key to some aggressive forms of prostate cancer

A newly published study by researchers at the University of Michigan has clarified the potential roles of a transcription factor called “forkhead box A1” (FOXA1) in hormone-driven forms of prostate cancer and some other forms of hormone-driven cancer (e.g., breast cancer). … READ MORE …

Genomic data and prostate cancer risk classification: an update

Three different molecular tests have been validated as providing useful data that can help a man and his doctors to come to decisions about the management and treatment of localized prostate cancer. … READ MORE …

Decision aids and prostate cancer: how useful are they?

Your sitemaster has long had concerns about the real value of decision aids in helping men to think about and come to conclusions about controversial issues in the diagnosis and management of prostate cancer. … READ MORE …